May 12, 2020 / 10:16 PM / 22 days ago

BRIEF-Turning Point Therapeutics Posts Quarterly Net Loss Per Share, Basic And Diluted $ 1.69

May 12 (Reuters) - Turning Point Therapeutics Inc:

* TURNING POINT THERAPEUTICS REPORTS FIRST-QUARTER FINANCIAL RESULTS, PROVIDES UPDATE ON OPERATIONS AND COVID-19 RESPONSE

* CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES OF $381 MILLION EXPECTED TO FUND CURRENT OPERATIONS INTO 2022

* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $ 1.69

* Q1 EARNINGS PER SHARE VIEW $-0.66 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below